BIOMÉRIEUX HAS BEEN A PIONEER FOR OVER 60 YEARS
Pioneering work in diagnostics
Since 1963, bioMérieux has been one of the world's leading companies in the field of in vitro diagnostics, developing, manufacturing and distributing diagnostic solutions such as reagents, analysis systems, software and services for use in the medical and industrial sectors.
We are directly represented in 45 countries and serve more than 160 countries with the support of a large distribution network. In 2022, sales reached a volume of 3.6 billion euros, with over 90% of sales generated outside France.
More than 13,000 employees (Dec. 2022) contribute to the company's success worldwide with their commitment.
Approximately 12% of sales are reinvested in research and development at 14 centres worldwide. bioMérieux's production facilities are located in the United States, France, Germany and Italy, among other countries. bioMérieux offers diagnostic solutions that can be used to determine the origin of diseases and contamination in order to improve patient health and ensure consumer safety.
In vitro diagnostics for infectious diseases, cardiovascular diseases and tumours, as well as therapy monitoring, are the focus of the clinical sector. Products and solutions are offered in the disciplines of microbiology, immunoassays and molecular biology.
In the industrial sector, bioMérieux covers a wide range of solutions for microbiological control in the food, pharmaceutical and cosmetics industries. Whether it's air and surface monitoring or automated identification, bioMérieux stands for reliable and reproducible microbiological results
bioMérieux Deutschland GmbH | www.biomerieux.com
